Physician profile
Eric J Seifter
NPI 1376544841
$340.05
in general payments reported to CMS, 2019-2025
12 companies · $56.46 in 2025
The $56.46 reported for 2025 was less than what a typical Hematology & Oncology provider received nationally (typical 2025 total: $686).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $51.40 · 2021: $15.81 · 2022: $28.02 · 2023: $84.95 · 2024: $103 · 2025: $56.46.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $219 · Education: $25.72.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $219.10 |
| Education | $25.72 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $78.66 | 2023-2024 | Prolia, Evenity, Otezla |
| Exelixis INC. | $51.40 | 2019 | |
| Pfizer INC. | $37.85 | 2025 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $34.87 | 2023-2025 | Xifaxan, Trulance |
| Eusa Pharma (US) LLC | $28.02 | 2022 | |
| Legend Biotech USA INC. | $25.72 | 2024 | Carvykti |
| Nevro Corp. | $17.53 | 2023 | Senza |
| Astellas Pharma US INC | $16.29 | 2024 | Veozah |
| Glaxosmithkline, LLC. | $15.81 | 2021 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $15.06 | 2023 | Tradjenta, Synjardy |
| Servier Pharmaceuticals LLC | $14.99 | 2023 | |
| Organon LLC | $3.85 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Eric Seifter listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.